Life Science & Biotech

Lilly scientists stole $55 million in trade secrets, indictment alleges

October 8, 2013
J.K. Wall
Three former employees of Eli Lilly and Co. allegedly transferred trade secrets that Lilly values at more than $55 million to a competing Chinese drug company, according to an indictment unsealed Tuesday in federal court.
More

Dow Agro wins latest patent case involving Enlist product

October 8, 2013
 IBJ Staff
The suit, filed in January 2012 by South African-based Bayer CropScience SA, charged that Dow Agro’s Enlist E3 soybean seed infringed one of its patents.
More

Technology on track to dramatically change health care

October 5, 2013
J.K. Wall
Cost pressures are forcing health care providers to extend the reach of limited resources.
More

Pence pleads for end to medical device tax

October 1, 2013
 The Statehouse File
Republican Gov. Mike Pence wrote a letter Monday urging members of the U.S. Senate to vote to repeal the medical device tax that is helping to finance Obamacare. But the Senate on Monday night voted not to repeal the tax, with all 54 Democrats voting to keep it.
More

Auction lands $2.1 million for Elona Biotech assets

September 27, 2013
 IBJ Staff
Elona went into receivership in June after Greenwood officials filed a foreclosure lawsuit against the firm. The company failed after receiving more than $8 million in economic development incentives from the city over the past three years.
More

Device prices plunge as hospitals pay less to fix hearts, hips

September 23, 2013
Bloomberg News
Prices paid in the United States for medical devices, including those made by Indiana-based manufacturers, have plunged as much as one-third since 2007 as hospitals clamped down on spending.
More

After years of success, Harlan Laboratories caught in debt viseRestricted Content

September 7, 2013
Greg Andrews
The company may violate loan covenants in the next three to six months, and its ability to refinance a $280 million loan that matures in July 2014 is “highly questionable,” Moody’s says.
More

Greenwood biotech firm's assets to hit auction block

September 3, 2013
 IBJ Staff
The remnants of ill-fated Elona Biotechnologies Inc. will be auctioned on Sept. 27, presenting a rare turnkey opportunity for entrepreneurs interested in jumping into the life sciences industry.
More

Board suggested busy Evans let go of AIT

August 5, 2013
J.K. Wall
Michael Evans was juggling two companies and two newborn twins when his board of directors suggested it was time for a new CEO of AIT Laboratories. He was replaced by venture capitalist Matt Neff on Monday.
More

Life sciences venture capital dips againRestricted Content

August 3, 2013
J.K. Wall
Venture capital surged in the first half of 2012, to $51.6 million in Indiana. But the pace of activity here fell off sharply in the second half of last year, and remained sluggish into 2013.
More

Zimmer earnings fall on legal reserve costs

July 25, 2013
Associated Press
Zimmer Holdings saw second-quarter earnings slump 29 percent as the orthopedic device maker set aside an additional $47 million to cover the cost of lawsuits related to its Durom hip cups.
More

Dow AgroSciences posts record second-quarter sales

July 25, 2013
 IBJ Staff and Associated Press
The Indianapolis-based maker of agricultural products, a unit of Michigan-based Dow Chemical Co., said revenue increased 10 percent from the year-ago period.
More

Universities' patents often lack commercial applicationsRestricted Content

July 6, 2013
Dan Human
The state's universities crank out patents that find their way to pharmaceutical, prosthetics and surgery technology companies. But they also generate reams of patents in areas with few industrial applications.
More

Cook Group looking forward to next 50 years

July 2, 2013
Associated Press
For leaders of a company looking back on 50 years of existence, Cook Group President Kem Hawkins and Chairman Steve Ferguson spend a lot of time talking about the future.
More

Lilly Endowment to give $10M to start biosciences institute

June 27, 2013
J.K. Wall
The institute aims to attract 100 new scientists to Indiana to conduct research and development work aimed at launching new therapies for metabolic diseases.
More

Most of Indiana's largest public companies enjoyed strong 2012Restricted Content

June 15, 2013
Angie's List turned a profit for the first time in nearly two decades.
More

Lilly halts trial of experimental Alzheimers drug

June 14, 2013
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a statement.
More

Bio-Response expanding in Hendricks County

June 10, 2013
 IBJ Staff
Wastewater equipment maker is moving to a Danville business park to build a $1.1 million facility.
More

New institute aims to attract 100 research scientists to Indiana

May 30, 2013
J.K. Wall
The $360 million initiative will be formally launched on Thursday by Gov. Mike Pence, executives of five major life sciences companies and officials of the state’s research universities.
More

Mobile health apps could cut into state companies' market share

May 18, 2013
J.K. Wall
The future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source: smartphone apps.
More

PINCUS: State needs better life sciences startup ecosystem

May 18, 2013
Jack Pincus / Special to IBJ
Indiana’s life sciences sector is mostly composed of legacy companies.
More

Report: Roche mulls sale of blood-glucose monitor business

May 17, 2013
J.K. Wall
Roche Diagnostics Corp. is considering a sale of its blood-glucose meter business, a move that would cast uncertainty over the nearly 1,000 people working for its diabetes business in Indianapolis.
More

PANEL: Life sciences will see radically different futureRestricted Content

May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues of venture capital, digital health innovations and research university entrepreneurship.

Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.

The following is an unedited transcript of the discussion.

More

New seed fund aims to make Indiana a hotbed for digital health startupsRestricted Content

May 4, 2013
J.K. Wall
Infuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
More

Lilly suing J&J for patent rights in Alzheimer's drug race

April 25, 2013
Bloomberg News
Eli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay availability of a potential treatment for Alzheimer’s disease.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Gay marriage is coming, whether or not these bigots and zealots like it or not. We must work to ensure future generations remember the likes of Greg Zoeller like they do the racists of our past...in shame.

  2. Perhaps a diagram of all the network connections of all politicians to their supporters and those who are elite/wealthy and how they have voted on bills that may have benefited their supporters. The truth may hurt, but there are no non-disclosures in government.

  3. I'm sure these lawyers were having problems coming up with any non-religious reason to ban same-sex marriage. I've asked proponents of this ban the question many times and the only answers I have received were religious reasons. Quite often the reason had to do with marriage to a pet or marriage between a group even though those have nothing at all to do with this. I'm looking forward to less discrimination in our state soon!

  4. They never let go of the "make babies" argument. It fails instantaneously because a considerable percentage of heterosexual marriages don't produce any children either. Although if someone wants to pass a law that any couple, heterosexual or homosexual, cannot be legally married (and therefore not utilize all legal, financial, and tax benefits that come with it) until they have produced a biological child, that would be fun to see as a spectator. "All this is a reflection of biology," Fisher answered. "Men and women make babies, same-sex couples do not... we have to have a mechanism to regulate that, and marriage is that mechanism." The civil contract called marriage does NOTHING to regulate babymaking, whether purposefully or accidental. These conservatives really need to understand that sex education and access to birth control do far more to regulate babymaking in this country. Moreover, last I checked, same-sex couples can make babies in a variety of ways, and none of them are by accident. Same-sex couples often foster and adopt the children produced by the many accidental pregnancies from mixed-sex couples who have failed at self-regulating their babymaking capabilities.

  5. Every parent I know with kids from 6 -12 has 98.3 on its car radio all the time!! Even when my daughter isn't in the car I sometimes forget to change stations. Not everybody wants to pay for satellite radio. This will be a huge disappointment to my 9 year old. And to me - there's so many songs on the radio that I don't want her listening to.

ADVERTISEMENT